ViewusGlobal on MSN2 小时
FDA Apporoves ‘Alhemo’ to Help Hemophilia Patients Manage Bleeding
Novo Nordisk’s hemophilia treatment has received approval from the U.S. Food and Drug Administration (FDA). The FDA has ...
Managed Healthcare Executive3 天
Alhemo Once-Daily Treatment for Hemophilia A, B with Inhibitors FDA Approved
The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...
Medscape5 天
Prevalence, Symptoms and Management of Uterine Fibroids
[23,24] Symptomatic women typically complain about abnormal uterine bleeding, specifically in terms of heavy and prolonged bleeding. [25] In a study of Wegienka et al. (2004) women with myomas ...
ViewusGlobal on MSN1 个月
Scurvy in the 21st Century? Growing Need for Vitamin C Awareness
Early signs include fatigue, loss of appetite, joint pain, and prolonged bleeding. As the condition worsens, hematomas may ...
The Financial Express15 天
First-in-human indigenous gene therapy for Hemophilia A shows significant positive outcomes
Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...